According to BioCryst Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โฌ0.51 Billion. In 2024 the company made a revenue of โฌ0.43 Billion an increase over the revenue in the year 2023 that were of โฌ0.29 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.